Monday, December 23, 2024
HomeTagsOrsoBio

OrsoBio

OrsoBio Secures $67M Series B for Mitochondrial Obesity Treatments

OrsoBio, Inc, a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders, announced the close of an oversubscribed $67 million Series B financing....
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics